NK Cell Levels Correlate with Disease Activity in Patients with Multiple Sclerosis on Ocrelizumab/Rituximab Therapy

• Main Authors: Simone Dal Bello (Author), Simone Lorenzut (Author), Emma Saccomano (Author), Yan Tereshko (Author), Gian Luigi Gigli (Author), Carlo Ennio Pucillo (Author), Mariarosaria Valente (Author)
• Formato: Livro
• Publicado em: MDPI AG, 2024-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Recently, research on the pathogenesis of multiple sclerosis (MS) has focused on the role of B lymphocytes and the possibility of using specific drugs, such as Ocrelizumab and Rituximab, directed toward these cells to reduce inflammation and to slow disease progression. Objective: We aim...